Adam Rosa Od INC
Adam Rosa Od INC was paid $18K by Medicaid between Nov 2022 and Sep 2024, across 6 billing codes. Its largest line is 92004, Ophthalmological services: medical examination and evaluation, comprehensive, new patient — 50% of everything it billed.
33Billing provider infoADAM ROSA OD INC
OCEANSIDE, CA 92058
OCEANSIDE, CA 92058
33aNPI1992450027assigned 02/17/2022
33bProvider typeOptometrist
28Total paid$18K
24GClaims1,501
24DCodes billed6
24AFirst – last monthNov 2022 – Sep 2024
Compared with peers
Next to other Optometrist providers in California
Rank by total paid#1,014 of 1,899
Median peer was paid$23K
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 160 | $2K | |
| 2023 | 1,025 | $12K | |
| 2024incomplete | 316 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 50% | 386 | 386 | $9K |
| 92015 | Determination of refractive state | 22% | 829 | 828 | $4K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 15% | 116 | 116 | $3K |
| V2020 | Frames, purchases | 8.7% | 115 | 115 | $2K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 3.0% | 43 | 43 | $562.31 |
| 92341 | 1.4% | 12 | 12 | $257.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSA, ADAM (PRESIDENT)